Curidium Medica joins USA's PMC

London, UK-based personalized medicine company Curidium Medica has joined the USA-based Personalized Medicine Coalition, an organization publicly launched in November 2004 by more than a dozen leading pharmaceutical, biotechnology, diagnostics and information technology companies, along with major academic centers and governmental agencies.

The PMC is an independent, non-profit group dedicated to advancing the understanding and adoption of personalized medicine concepts and products for the benefit of patients, representing over 100 members. The Coalition seeks to promote discussion and understanding that will lead to the development of sound public policy on matters that affect the realization of personalized medicine, Curidium noted.

"The PMC has become the key organization in shaping US public policy on personalized medicine. We believe the PMC will be instrumental in making personalized medicine a reality," said Anne Bruinvels, chief executive of the UK firm. "We are very pleased to be a member of a group that will dramatically impact the treatment of patients in the future," she added.